Aeglea BioTherapeutics To Evaluate Combination Treatment With Merck For Small Cell Lung Cancer

Aeglea BioTherapeutics To Evaluate Combination Treatment With Merck For Small Cell Lung Cancer

Aeglea BioTherapeutics (AGLE) said Monday it will collaborate with Merck (MRK) to evaluate the combination of Aeglea’s AEB1102 with Merck’s Keytruda for the treatment of patients with small cell lung cancer (SCLC). “Given the emerging relevance of checkpoint inhibitors, such as Keytruda in SCLC, this collaboration represents an exciting step forward for Aeglea as we investigate the potential of [AEB1102] to treat this devastating disease,” said Aeglea’s chief medical officer […]

Read More ˃
Colony NorthStar Makes Investment in The Weinstein Company

Colony NorthStar Makes Investment in The Weinstein Company

Colony NorthStar (CLNS) has made an “immediate capital infusion” into The Weinstein Company and has entered a negotiating period with the movie production company for a potential sale of all or a significant portion of its assets. Financial terms of the investment by Colony weren’t disclosed. “We believe that Colony’s investment and sponsorship will help stabilize [The Weinstein Company’s] current operations, as well as provide comfort to our critical distribution, […]

Read More ˃
Health Insurance Innovations Expects Higher Q3 Adjusted EPS

Health Insurance Innovations Expects Higher Q3 Adjusted EPS

Health Insurance Innovations (HIIQ), a developer, distributor, and cloud-based administrator of affordable health plans, said that based on preliminary Q3 results it expects to report GAAP diluted earnings per share in the range of $0.26 to $0.30 and adjusted earnings per share of between $0.44 to $0.46. The GAAP EPS would be 4% to 20% up from the comparable prior year period and adjusted EPS would 33% to 39% higher […]

Read More ˃
European ADRs Little Changed as Pharma Gains Offset Banking Losses

European ADRs Little Changed as Pharma Gains Offset Banking Losses

American depository receipts of European stocks were 0.03% higher at 140.62 on the Bank of New York Mellon Europe ADR Index on Monday morning. Gainers in Continental Europe were led by Novo Nordisk (NVO), a Danish healthcare company, up by 3.9%, followed by DBV Technologies (DBVT), a French clinical-stage biopharmaceutical company, up by 2.4%, voxelJet (VJET), a German three-dimensional printer manufacturer, 2.2% higher and Advanced Accelerator Applications (AAAP), a radiopharmaceutical […]

Read More ˃
British Subprime Lender Provident Draws Up Recovery Plan for Troubled Consumer Credit Business

British Subprime Lender Provident Draws Up Recovery Plan for Troubled Consumer Credit Business

British subprime lender Provident Financial (PFG.L, PFS), said on Friday it developed a recovery unit for the loss-making door-to-door lending business following a profit warning in August. Under its plan to revive the division, Provident will establish four UK divisions at its home credit business instead of the two it has currently, increase the number of regional managers, and recruit at least 300 part-time staff, mainly people who used to […]

Read More ˃